Brief: Crinetics Pharmaceuticals Q3 Net Income USD -130.091 Million
06/11/2025 21:05
Nov 06 (Reuters) - Crinetics Pharmaceuticals Q3 revenue USD 143 thousand vs. IBES estimate USD 637.2 thousand. Q3 operating expenses USD 142.729 million Q3 basic EPS USD -1.38 Q3 operating income USD -142.586 million
Recent news on Crinetics Pharmaceuticals
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Crinetics Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Crinetics Q2 revenue jumps on PALSONIFY launch, withdraws guidance
Brief: Crinetics Pharmaceuticals Q2 Net Income USD -120.855 Million